Addus HomeCare (NASDAQ:ADUS) Stock: Insider R Dirk Allison Sells 98,958 Shares

Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) CEO R. Allison sold 98,958 shares of the business’s stock in a transaction on Monday, November 9th. The shares were sold at an average price of $123.27, for a total transaction of $12,198,552.66. Following the transaction, the chief executive officer directly owned 183,150 shares of the company’s stock, valued at approximately $22,576,900.50. This trade represents a 35.08% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Addus HomeCare Stock Performance

Shares of ADUS stock traded up $3.87 during trading hours on Tuesday, reaching $126.29. The stock had a trading volume of 225,844 shares, compared to its average volume of 237,872. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.64 and a quick ratio of 1.69. Addus HomeCare Corporation has a twelve month low of $87.95 and a twelve month high of $131.59. The firm has a 50-day simple moving average of $117.74 and a 200-day simple moving average of $106.95. The firm has a market capitalization of $2.36 billion, a PE ratio of 21.05, a price-to-earnings-growth ratio of 1.82 and a beta of 0.75.

Addus HomeCare (NASDAQ:ADUS – Get Free Report) last posted its earnings results on Tuesday, November 3rd. The company reported $1.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.79 by $0.04. Addus HomeCare had a net margin of 7.39% and a return on equity of 10.22%. The firm had revenue of $387.74 million during the quarter, compared to analyst estimates of $388.72 million. During the same period in the previous year, the business posted $1.56 EPS. Addus HomeCare’s revenue was up 7.0% on a year-over-year basis. As a group, equities analysts forecast that Addus HomeCare Corporation will post 6.34 earnings per share for the current year.

Hedge Funds Weigh In On Addus HomeCare

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in shares of Addus HomeCare in the 2nd quarter worth $344,153,000. Dimensional Fund Advisors LP grew its holdings in Addus HomeCare by 11.8% during the first quarter. Dimensional Fund Advisors LP now owns 744,127 shares of the company’s stock worth $69,689,000 after acquiring an additional 78,415 shares during the period. Bank of America Corp DE acquired a new position in Addus HomeCare during the second quarter worth about $35,527,000. TimesSquare Capital Management LLC bought a new stake in Addus HomeCare in the second quarter worth about $31,502,000. Finally, Allspring Global Investments Holdings LLC raised its position in Addus HomeCare by 110.5% in the third quarter. Allspring Global Investments Holdings LLC now owns 189,718 shares of the company’s stock worth $21,192,000 after acquiring an additional 99,596 shares in the last quarter. 95.35% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently commented on ADUS shares. Barclays raised their target price on Addus HomeCare from $96.00 to $101.00 and gave the company an “underweight” rating in a research report on Wednesday, November 4th. Truist Financial increased their price target on Addus HomeCare from $135.00 to $148.00 and gave the stock a “buy” rating in a research note on Thursday, November 5th. Royal Bank Of Canada raised their price target on Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. Citigroup lowered shares of Addus HomeCare from a “market outperform” rating to a “neutral” rating in a research report on Monday, September 14th. Finally, Weiss Ratings raised shares of Addus HomeCare from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, September 24th. Seven equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Addus HomeCare has an average rating of “Moderate Buy” and an average target price of $134.70.

Check Out Our Latest Report on Addus HomeCare

About Addus HomeCare

(Get Free Report)

Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.

Read More

Insider Buying and Selling by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.